AI Article Synopsis

  • The study aimed to understand patient perspectives on harm reduction practices in emergency departments (ED) for individuals with opioid use disorder.
  • Participants were interviewed to identify barriers and facilitators related to accessing harm reduction strategies, focusing on issues like stigma and the availability of resources.
  • Findings highlighted the need for user-centered interventions in the ED that address accessibility, stigma reduction, and support for withdrawal symptoms.

Article Abstract

Study Objective: Although an increasing number of emergency departments (ED) offer opioid agonist treatment, naloxone, and other harm reduction measures, little is known about patient perspectives on harm reduction practices delivered in the ED. The objective of this study was to identify patient-focused barriers and facilitators to harm reduction strategies in the ED.

Methods: We conducted semistructured interviews with a convenience sample of individuals in Massachusetts diagnosed with opioid use disorder. We developed an interview guide, and interviews were recorded, transcribed, and analyzed in an iterative process using reflexive thematic analysis. After initial interviews and coding, we triangulated the results among a focus group of 4 individuals with lived experience.

Results: We interviewed 25 participants with opioid use disorder, 6 recruited from 1 ED and 19 recruited from opioid agonist treatment clinics. Key themes included accessibility of harm reduction supplies, lack of self-care resulting from withdrawal and hopelessness, the impact of stigma on the likelihood of using harm reduction practices, habit and knowledge, as well as the need for user-centered harm reduction interventions.

Conclusion: In this study, people with lived experience discussed the characteristics and need for user-centered harm reduction strategies in the ED that centered on reducing stigma, treatment of withdrawal, and availability of harm reduction materials.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10960719PMC
http://dx.doi.org/10.1016/j.annemergmed.2023.11.020DOI Listing

Publication Analysis

Top Keywords

harm reduction
36
opioid disorder
12
harm
9
reduction
9
barriers facilitators
8
facilitators harm
8
study people
8
people lived
8
lived experience
8
opioid agonist
8

Similar Publications

Harm reduction associated with heated tobacco products: A systematic review and meta-analysis.

Pak J Med Sci

January 2025

Professor Khalid S. Khan, MSc. Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

Objective: We conducted a systematic review and meta-analysis of randomised studies in humans comparing the outcomes of switching to heated tobacco products (HTPs) versus continuing conventional tobacco smoking by burning.

Methods: We searched the electronic databases which included PubMed, Web of Science, Cochrane Controlled Trials Register, and Google Scholar from inception to May 2023. Randomised Controlled Trials (RCTs) in humans comparing HTPs with conventional burnt tobacco products were selected.

View Article and Find Full Text PDF

Background: Healthcare is a major contributor to global greenhouse gas emissions. Colorectal cancer (CRC) screening is one of the most widely used healthcare services in the US, indicated for approximately 134 million adults. Recommended screening options include fecal immunochemical tests (FITs) every year, CT colonographies (CTCs) every 5 years, or colonoscopies every 10 years.

View Article and Find Full Text PDF

Background: To address high levels of drug-related harms among people who inject drugs (PWID) in Glasgow, a novel contingency management intervention was developed to engage high-risk PWID with four harm reduction measures (known as the WAND initiative: ound care, ssessment of injecting, aloxone, and ried blood-spot test). Our aims were to assess if WAND engaged and re-engaged high-risk PWID.

Methods: Baseline data of WAND participants (n = 831) from 1st Sept-2020 to 30th Aug-2021 were analysed.

View Article and Find Full Text PDF

Safer Stimulant Supply: Program Outcomes.

Can J Nurs Res

January 2025

School of Nursing, University of Ottawa, Ottawa, ON, Canada.

Objectives: With nearly 50,000 people having died since 2016 as a result of the unregulated toxic drug supply, novel approaches to care are needed. A small number of Safer Stimulant Supply programs have been piloted in Canada, which seek to provide a pharmaceutical-grade stimulant medication replacement for the toxic unregulated stimulant supply. In this paper, we describe the results of retrospective Safer Stimulant Supply program medical chart reviews.

View Article and Find Full Text PDF

The COVID-19 pandemic has significantly influenced substance prevention work, exacerbating existing challenges and providing new opportunities for community-based substance prevention networks (CSPNs). CSPNs are interorganizational networks that include various providers, such as nonprofits and government agencies, that collaborate to provide substance prevention services and are embedded in local communities. This study analyzes the post-pandemic adaptation of a CSPN in the United States.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!